JP2007518767A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007518767A5 JP2007518767A5 JP2006550041A JP2006550041A JP2007518767A5 JP 2007518767 A5 JP2007518767 A5 JP 2007518767A5 JP 2006550041 A JP2006550041 A JP 2006550041A JP 2006550041 A JP2006550041 A JP 2006550041A JP 2007518767 A5 JP2007518767 A5 JP 2007518767A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- hydrogen
- phenyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0401336.3A GB0401336D0 (en) | 2004-01-21 | 2004-01-21 | Organic compounds |
| PCT/EP2005/000542 WO2005070926A1 (en) | 2004-01-21 | 2005-01-20 | Thiazole derivatives as a2b antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007518767A JP2007518767A (ja) | 2007-07-12 |
| JP2007518767A5 true JP2007518767A5 (pt-PT) | 2008-03-21 |
Family
ID=31971241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006550041A Pending JP2007518767A (ja) | 2004-01-21 | 2005-01-20 | Ａ２ｂアンタゴニストとしてのチアゾール誘導体 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20090233938A1 (pt-PT) |
| EP (1) | EP1709036B1 (pt-PT) |
| JP (1) | JP2007518767A (pt-PT) |
| KR (1) | KR20060129276A (pt-PT) |
| CN (1) | CN1910178B (pt-PT) |
| AT (1) | ATE388147T1 (pt-PT) |
| AU (1) | AU2005206290B2 (pt-PT) |
| BR (1) | BRPI0506927A (pt-PT) |
| CA (1) | CA2553010A1 (pt-PT) |
| DE (1) | DE602005005161T2 (pt-PT) |
| ES (1) | ES2300985T3 (pt-PT) |
| GB (1) | GB0401336D0 (pt-PT) |
| PL (1) | PL1709036T3 (pt-PT) |
| PT (1) | PT1709036E (pt-PT) |
| RU (1) | RU2374242C2 (pt-PT) |
| WO (1) | WO2005070926A1 (pt-PT) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2270715B1 (es) | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
| EP1926719B1 (en) * | 2005-09-13 | 2017-05-31 | Janssen Pharmaceutica NV | 2-aniline-4-aryl substituted thiazole derivatives |
| ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| CA2646333C (en) * | 2006-03-17 | 2014-06-17 | Cv Therapeutics, Inc. | Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists |
| WO2007134958A1 (en) * | 2006-05-18 | 2007-11-29 | F. Hoffmann-La Roche Ag | Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists |
| RU2474579C2 (ru) | 2007-10-18 | 2013-02-10 | Янссен Фармацевтика Нв | Тризамещенные 1,2,4-триазолы |
| JO2784B1 (en) | 2007-10-18 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | 5,3,1 - Triazole substitute derivative |
| AU2009226988B2 (en) | 2008-03-19 | 2013-05-23 | Janssen Pharmaceutica Nv | Trisubstituted 1, 2, 4 -triazoles as nicotinic acetylcholine receptor modulators |
| JP5486591B2 (ja) | 2008-05-09 | 2014-05-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | アセチルコリン受容体モジュレーターとしての三置換ピラゾール |
| US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
| ES2580702B1 (es) | 2015-02-25 | 2017-06-08 | Palobiofarma, S.L. | Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina |
| CN109293652B (zh) * | 2017-07-24 | 2021-10-22 | 四川科伦博泰生物医药股份有限公司 | 一种取代的噻唑衍生物及其用途 |
| CN109651358B (zh) * | 2017-10-11 | 2023-04-07 | 上海迪诺医药科技有限公司 | 4-氨基吡啶衍生物、其药物组合物、制备方法及应用 |
| JP7510426B2 (ja) | 2018-10-24 | 2024-07-03 | リードエックスプロ アーゲー | 官能化されたアミノトリアジン |
| US20200345725A1 (en) | 2019-01-11 | 2020-11-05 | Omeros Corporation | Methods and Compositions for Treating Cancer |
| WO2023139132A1 (en) * | 2022-01-19 | 2023-07-27 | Leadxpro Ag | Functionalized aminothiazoles |
| GB2615307A (en) * | 2022-01-28 | 2023-08-09 | Adorx Therapeutics Ltd | Antagonist compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999064418A1 (en) * | 1998-06-05 | 1999-12-16 | Novartis Ag | Aryl pyridinyl thiazoles |
| JP2000281685A (ja) * | 1999-01-28 | 2000-10-10 | Takeda Chem Ind Ltd | チアゾロピリミジン化合物、その製造法および用途 |
| WO2001030778A1 (en) * | 1999-10-27 | 2001-05-03 | Novartis Ag | Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use |
| GB0028383D0 (en) * | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| JP2002302445A (ja) * | 2001-02-02 | 2002-10-18 | Takeda Chem Ind Ltd | Ｊｎｋ阻害剤 |
| GB0123589D0 (en) * | 2001-10-01 | 2001-11-21 | Syngenta Participations Ag | Organic compounds |
| JP2005510508A (ja) * | 2001-11-08 | 2005-04-21 | 藤沢薬品工業株式会社 | アデノシンアンタゴニストとしてのチアゾールピリダジノン類 |
-
2004
- 2004-01-21 GB GBGB0401336.3A patent/GB0401336D0/en not_active Ceased
-
2005
- 2005-01-20 AU AU2005206290A patent/AU2005206290B2/en not_active Ceased
- 2005-01-20 EP EP05706936A patent/EP1709036B1/en not_active Not-in-force
- 2005-01-20 AT AT05706936T patent/ATE388147T1/de not_active IP Right Cessation
- 2005-01-20 KR KR1020067014629A patent/KR20060129276A/ko not_active Application Discontinuation
- 2005-01-20 PL PL05706936T patent/PL1709036T3/pl unknown
- 2005-01-20 BR BRPI0506927-0A patent/BRPI0506927A/pt not_active IP Right Cessation
- 2005-01-20 CA CA002553010A patent/CA2553010A1/en not_active Abandoned
- 2005-01-20 DE DE602005005161T patent/DE602005005161T2/de active Active
- 2005-01-20 CN CN2005800026886A patent/CN1910178B/zh not_active Expired - Fee Related
- 2005-01-20 ES ES05706936T patent/ES2300985T3/es active Active
- 2005-01-20 US US10/585,614 patent/US20090233938A1/en not_active Abandoned
- 2005-01-20 RU RU2006130002/04A patent/RU2374242C2/ru not_active IP Right Cessation
- 2005-01-20 WO PCT/EP2005/000542 patent/WO2005070926A1/en active Application Filing
- 2005-01-20 PT PT05706936T patent/PT1709036E/pt unknown
- 2005-01-20 JP JP2006550041A patent/JP2007518767A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007518767A5 (pt-PT) | ||
| JP4792025B2 (ja) | ５−ヒドロキシインドール−３−カルボン酸エステル類誘導体およびその用途 | |
| JP2019510787A5 (pt-PT) | ||
| JP2018507890A5 (pt-PT) | ||
| JP2006509749A5 (pt-PT) | ||
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| AU707144B2 (en) | Acylated N-hydroxymethyl thalidomide prodrugs having an immunomodulatory effect | |
| JP2006517939A5 (pt-PT) | ||
| JP2007269797A5 (pt-PT) | ||
| JP2011507878A5 (pt-PT) | ||
| RU2007109598A (ru) | Кристаллическая форма бифенильного соединения | |
| RU2006130002A (ru) | ПРОИЗВОДНЫЕ ТРИАЗОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ А2b | |
| JP2010501003A5 (pt-PT) | ||
| JP2009507909A5 (pt-PT) | ||
| JP2007522142A5 (pt-PT) | ||
| RU2005135016A (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| KR20150093685A (ko) | Hbv 어셈블리 이펙터의 대체 용도 | |
| CA2679198A1 (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| JP2009535340A5 (pt-PT) | ||
| RU2007108863A (ru) | Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3 | |
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| JP2008538779A5 (pt-PT) | ||
| JP2013540114A5 (pt-PT) | ||
| CN1165522C (zh) | 缓激肽受体拮抗剂 | |
| JP2003306481A5 (pt-PT) |